Fidel Vila-Rodriguez, MD, PhD
- 2Articles
- 8.8KReads
- 2019–2025Active
- 55Collaborators
- 82Citations
About
Fidel Vila-Rodriguez, MD, PhD, is affiliated with the Invasive Neurostimulation Therapies Laboratory and the Department of Psychiatry at the University of British Columbia, as well as its School of Biomedical Engineering. Vila-Rodriguez has published research focused on major depressive disorder (MDD), specifically investigating treatment-resistant depression, antidepressant response, and augmentation strategies involving aripiprazole, repetitive transcranial magnetic stimulation, and escitalopram. The author’s work includes comparative effectiveness trials and studies on symptomatic and functional outcomes in depression management. Frequent collaborators include Albert S. Yeung, Alexander Bystritsky, Anthony L. Vaccarino, Arun V. Ravindran, and Benicio N. Frey.
Publications
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
August 11, 2025
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.